
1.77 Delayed Data As of Sep 20 | ![]() Today’s Change | 1.25 Today|||52-Week Range 5.64 | -46.04% Year-to-Date |
Previous close | 1.58 |
Today’s open | 1.69 |
Day’s range | 1.65 - 1.96 |
Volume | 3,280,126 |
Average volume (3 months) | 1,625,177 |
Market cap | $154.7M |
Earnings growth (last year) | +38.36% |
Earnings growth (this year) | -11.75% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +212.55% |
P/E ratio | NM |
Price/Sales | 5.26 |
Price/Book | 1.16 |
Today’s change | Today’s % change | |
---|---|---|
ADVMAdverum Biotechnolog... | +0.02 | +1.26% |
ADAPAdaptimmune Therapeu... | +0.02 | +2.41% |
MRSNMersana Therapeutics... | -0.08 | -5.93% |
HRTXHeron Therapeutics I... | -0.01 | -0.88% |
Next reporting date | November 7, 2023 |
EPS forecast (this quarter) | -$0.64 |
Annual revenue (last year) | $63.6M |
Annual profit (last year) | -$228.3M |
Net profit margin | -359.12% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Thousand Oaks, California |